Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. > Summary
Court Case Number 1:23-cv-00551
Filing Date May 19, 2023
Court Delaware District Court
Status Unknown
JudgesRichard G. Andrews
Plaintiff
4Defendant
Plaintiff Attorneys
6BAYER AKTIENGESELLSCHAFT ("BAYER AG")
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
BAYER AKTIENGESELLSCHAFT ("BAYER AG")
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
BAYER AKTIENGESELLSCHAFT ("BAYER AG")
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
Defendant Attorneys
3Teva Pharmaceuticals
Attorney Name: John W. Shaw
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Karen E. Keller
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10828310 | Reducing the risk of cardiovascular events | Nov 10, 2020 |
